Endometrial Ablation is a medical procedure that is used to either eliminate (abate) or disintegrate (disintegrate) the endometrial tissue of the uterus in patients who regularly have very heavy menstrual periods. There are three procedures that are commonly used for this procedure: Single-cell ablation, selective leucoplast, and laparoscopy-assisted ablation. Endometrial Ablation may also be referred to as "endometrium ligation". This is the name given to the procedure when a small hole is made in the outermost layer of the endometrial cells. Endometrial Ablation usually takes longer than other methods and can be painful for some women. Some patients report feeling pressure and pain in the abdominal area, pelvic area, or in the lower back while having the procedure.
Increasing number of various gynecological disorders is expected to drive growth of the global endometrial ablation market during the forecast period. The incidence of gynecological disorders such as ovarian cysts, pelvic pain, uterine cancer, vagina skin disorders, etc. has increased significantly. According to the Centers for Disease Control and Prevention (CDC), between 2012 and 2016 around 94,000 women were diagnosed with gynecologic cancer each year in the U.S. According to the same source, the most gynecologic cancer was uterine cancer with 26.82 cases per 100,000. Such a high incidence of uterine cancer, which causes vaginal bleeding after menopause and bleeding between periods has increased the adoption of endometrial ablation. Thus, these factors are expected to drive growth of the global endometrial ablation market during the forecast period. Moreover, increasing demand for minimally invasive surgical procedures is expected to boost the global endometrial ablation market growth over the forecast period.
However, an unfavorable regulatory framework combined with high costs related to ablation procedures is expected to hinder the global endometrial ablation market growth over the forecast period. Besides, the lack of reimbursement policies is expected to hamper the market growth in the near future. Among regions, North America is expected to witness significant growth in the global endometrial ablation market during the forecast period. This is owing to rapid technological advancements and the presence of robust healthcare infrastructure across the region. Moreover, Asia Pacific is expected to exhibit a lucrative growth rate over the forecast period, owing to increasing accessibility to novel endometrial ablation procedures in the region.
Key companies involved in the global endometrial ablation market are Boston Scientific Corporation, The Cooper Companies Inc., Olympus Corporation, Smith & Nephew, Minerva Surgical, Inc., Karl Storz GmbH & Co. KG, Richard Wolf GmbH, Ethicon, LLC, and Medtronic plc.
For instance, in May 2020, Minerva Surgical, a U.S.-based healthcare company, acquired Boston Scientific’s Intrauterine Health franchise with a commitment to eliminate Abnormal Uterine Bleeding (AUB).
No comments:
Post a Comment